The Villages, FL2 Active Studies

Parkinsons Disease Clinical Trials in The Villages, FL

Find 2 actively recruiting parkinsons disease clinical trials in The Villages, FL. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
183
Enrolling

Recruiting Parkinsons Disease Studies in The Villages

About Parkinsons Disease Clinical Trials in The Villages

Parkinson's disease is a progressive nervous system disorder that affects movement, causing tremors, stiffness, and difficulty with balance. It results from the loss of dopamine-producing neurons in the brain. Treatment includes medications, deep brain stimulation, and emerging therapies targeting disease modification.

There are currently 2 parkinsons disease clinical trials recruiting participants in The Villages, FL. These studies are seeking a combined 183 participants. Research is being sponsored by Eli Lilly and Company, Gateway Institute for Brain Research. Clinical trial participation is free and participants receive study-related medical care at no cost.

Parkinsons Disease Clinical Trials in The Villages — FAQ

Are there parkinsons disease clinical trials in The Villages?

Yes, there are 2 parkinsons disease clinical trials currently recruiting in The Villages, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Villages?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Villages research site will contact you about next steps.

Are clinical trials in The Villages free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Villages studies also compensate for your time and travel.

What parkinsons disease treatments are being tested?

The 2 active trials in The Villages are testing new therapies including novel drugs, biologics, and treatment approaches for parkinsons disease.

Data updated July 22, 2026 from ClinicalTrials.gov